What is Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterized by progressive degeneration of photoreceptor cells (rods and cones) and retinal pigment epithelial atrophy, leading to progressive vision loss and eventual blindness in both eyes 1, 2.
Disease Characteristics
RP represents the most common inherited retinal dystrophy and affects over 1 million people worldwide, with a prevalence of approximately 1 in 4,000 individuals 3. The condition demonstrates:
- Genetic heterogeneity: Over 90 genes have been implicated in causing RP, making it one of the most genetically diverse retinal conditions 1
- Gender distribution: More frequent in males (60%) compared to females (40%) 3
- Leading cause: First cause of blindness of genetic origin globally 3
Clinical Presentation and Progression
The disease follows a characteristic pattern of visual deterioration:
- Initial symptoms: Night blindness (nyctalopia) typically appears first due to rod photoreceptor degeneration
- Progressive field loss: Peripheral vision loss advances concentrically, creating "tunnel vision"
- Late-stage manifestations: Central vision deterioration occurs as cone photoreceptors degenerate, leading to legal and sometimes complete blindness 1
- Fundoscopic findings: Characteristic bone-spicule pigmentation in the retina, retinal vessel attenuation, and optic disc pallor
Pathophysiology
The fundamental pathologic process involves 4:
- Primary photoreceptor cell death (both rods and cones)
- Secondary retinal pigment epithelial atrophy
- Progressive retinal degeneration
- Multiple cell death pathways may be involved, contributing to heterogeneous disease presentation and treatment responses
Clinical Impact
Patients with RP experience profound physical and psychosocial difficulties that extend beyond vision loss, requiring comprehensive interventions for social-emotional conflicts 1. The condition results in debilitating visual impairment that significantly affects quality of life and activities of daily living 5.
Diagnostic Approach
Modern diagnosis relies heavily on:
- Next-generation sequencing: Critical for accurate genetic diagnosis and facilitating genotype-phenotype correlation 1
- Molecular biology techniques: Primary method for studying genetic characteristics, widely used in disease diagnosis and clinical trials 4
- Imaging and functional studies: Essential for diagnosis and estimating treatment outcomes 2
Current Treatment Landscape
While no definitive curative treatments exist, emerging therapeutic modalities show promise 5:
- Gene therapy: Most promising approach with favorable outcomes for visual function preservation and disease stabilization 5; already available for RPE-65 Leber's congenital amaurosis (infantile RP) 2
- Stem cell therapies: Demonstrate potential benefits, though evidence remains limited 5
- Other modalities: Optogenetics, retinal prosthetics, neuroprotective agents, and transcorneal electrical stimulation are under investigation 1, 6, 3
Important caveat: Some therapies show benefit early in disease but lose efficacy long-term 3, emphasizing the importance of early diagnosis and intervention.